Ligand Pharmaceuticals
LGND
LGND
207 hedge funds and large institutions have $1.67B invested in Ligand Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 70 increasing their positions, 80 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $2.51B → $1.67B (-$840M)
37% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 35
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
207
Holding in Top 10
1
Calls
$7.21M
Puts
$3.44M
Top Buyers
| 1 | +$23M | |
| 2 | +$8.29M | |
| 3 | +$7.27M | |
| 4 |
CC
Chicago Capital
Chicago,
Illinois
|
+$6.22M |
| 5 |
DMKJ
David M. Knott Jr
|
+$4.5M |
Top Sellers
| 1 | -$54.7M | |
| 2 | -$30.1M | |
| 3 | -$25.1M | |
| 4 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$13.3M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$6.75M |